Predictors of radiation dose for uterine artery embolisation are angiography system-dependent

Abstract

This study sought to achieve radiation dose reductions for patients receiving uterine artery embolisation (UAE) by evaluating radiation dose measurements for the preceding generation (Allura) and upgraded (Azurion) angiography system. Previous UAE regression models in the literature could not be applied to this centre’s practice due to being based on different angiography systems and radiation dose predictor variables. The aims of this study were to establish whether radiation dose is reduced with the upgraded angiography system and to develop a regression model to determine predictors of radiation dose specific to the upgraded angiography system. A comparison between Group I (Allura, n = 95) and Group II (Azurion, n = 95) demonstrated a significant reduction in KAP (kerma-area product) and Ka, r (reference air kerma) by 63% (143.2 Gy·cm2 vs 52.9 Gy·cm2; P < 0.001, d = 0.8) and 67% (0.6 Gy vs 0.2 Gy; P < 0.001, d = 0.8), respectively. The multivariable linear regression (MLR) model identified the UAE radiation dose predictors for KAP on the upgraded angiography system as total fluoroscopy dose, Ka, r, and total uterus volume. The predictive accuracy of the MLR model was assessed using a Bland-Altman plot. The mean difference was 0.39 Gy·cm2 and the limits of agreement (LoA) were +28.49 and -27.71 Gy·cm2, and thus illustrated no proportional bias. Our findings validated the upgraded angiography system and its advance capabilities to significantly reduce radiation dose for our patients. Interventional radiologist and interventional radiographer familiarisation of the system’s features and the implementation of the newly established MLR model would further facilitate dose optimisation for all centres performing UAE procedures using the upgraded angiography system.

[Retracted] Analysis of Causes and Results of Fetal Growth in Utero Caused by Genetic Factors Detected by Ultrasound

“…All pregnant women underwent the ultrasound examination at 20–24 weeks of gestation. The color ultrasound diagnostic instrument (GE VolusonE8) with a protruding array probe frequency of 3.5–5.0 MHz was used to check the growth of the fetal head circumference, abdominal circumference, biparietal diameter, femoral diameter, humeral diameter, amniotic fluid volume, and placenta [ 12 ]. UA, MCA, and UtA blood flow parameters were measured according to the guidelines of the International Society of Obstetrical Ultrasound.…”